Dystonia and Tourette Syndrome Flashcards

1
Q

Dystonia

A

Involuntary, sustained, patterned and repetitive co-contraction of agonist and antagonist muscles, causing twisting movements or abnormal posture
- antag and agonist muscles contract at same time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dystonia disorders

A

Group of disorders with very different etiology and pathophysiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classifications of dystonia

A
  • generalized (whole body)
  • segmental or focal (including torticollis,
    blepharospasm, Writer’s cramp)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dystonia triggers and length

A
  • Continuous, episodic or fluctuating
  • Triggered by specific acts (i.e. playing piano or writing) or by voluntary movements
  • Exacerbated by stress and fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Examples of focal dystonia

A
  • Writer’s cramp. Abnormal clenching of
    fingers occurs selectively during writing;
    the patient is otherwise normal.
  • Dystonia of arm, neck and face,
    exacerbated during writing. Patient first
    developed writer’s cramp, but subsequently developed dystonia of the neck (torticollis) and face.
  • Involuntary dystonic flexion of trunk
    and extension of neck (retrocollis) during
    gait.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Primary dystonia

A

occurs as an isolated sign in the absence of an identifiable neuropathological lesion or exogenous cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Secondary dystonia

A

result from a lesion to the motor system

(mainly putamen or globus pallidum), and is typically accompanied by additional neurological signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Primary dystonia is a _____, charcaterized by abnormal activity in multiple regions involved in ___ control and _____ including…

A

motor circuit disorder; motor control and sensorimotor integration
including spinal cord, brainstem, cerebellum, basal ganglia and
cerebral cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pathophysiology of dystonia

A

Overall dystonia is considered the result of deficient inhibition in cortical and subcortical areas –> Abnormal synchronization of presynaptic inputs to agonist and antagonist motor neuron pools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathophysiology Task-specific dystonia

A

Specific motor programs may be disrupted causing task-specific dystonia
ex. writing or piano playing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of sporadic dystonia

A
  • Antipsychotic treatments causing D2 receptor blockade
  • When unilateral it can be due to tumors, stroke or trauma
  • Peripheral trauma or muscle overuse determining topographic reorganization and abnormal plasticity of the somatosensory
    cortex.
  • Genetic mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Genetic mutations associated with dystonia

A
  • TORSIN A gene mutation
  • missense mutations in D2 receptor gene
  • L-DOPA responsive dystonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TORSIN A gene mutation

A
  • Torsin A is an ER chaperone enriched in dopaminergic neurons
  • involved in proper intracellular trafficking of Na+-K+ ATPase and GTP cyclohydrolase 1
    i. e. it is normally involved in trafiicking of membrane proteins –> mutations affect that
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

L-Dopa-responsive dystonia (Segawa syndrome)

A

mutation in the GTP-cyclohydrolase 1 (GCH1) gene, which catalyzes the first step in the synthesis of tetrahydrobiopterin (BH4), the cofactor for tyrosine hydroxylase (prevents DA production) lack of dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GTP-cyclohydrolase 1 (GCH1)

A

implicated in 2 genetic causes for dystonia (L-dopa responsive dystonia and Torsin A mutations)
Is a gene that forms the enzyme GTP-cyclohydrolase 1 (GCH1) which is an early enzyme in the formation of DA (the step from GTP to dihydronepoterin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

L-dopa treatment for dystonia

A
L-dopa in dopa-responsive dystonia and other forms of earlyonset dystonia. 
Small doses (much lower doses than used in PD) may provide complete relief from symptoms (complete remission)
17
Q

Targets of drugs for dystonia

A
Basal ganglia (l-dopa)
Spinal cord and neuromuscular junctions (baclofen, benzo, botulinum toxin and anticolinergics)
18
Q

Drugs that target the Spinal cord and neuromuscular junctions

A
AT neuromuscular junction
- Botulinum toxin
- anticholinergic (trihexyphenidyl)
AT SC
- baclofen
- benzos (clonazepan)
19
Q

Baclofen

A

Derivative of GABA, works as a presynaptic GABA-B receptor agonist, producing
neuronal hyperpolarization
and pre-synaptic inhibition.
- Primarily used to treat spasticity.
- can’t cross the BBB so administered intrathecally in cases of severe dystonia

20
Q

Benzodiazepines

A

GABA-A receptor agonists

ex. clonazepan
- less effective than baclofen and anticholinergics and produces sedation.

21
Q

Anticholinergic drugs

A

ex. trihexyphenidyl = muscarinic acetylcholine receptor antagonist
- first choice for adults
- second for children after L-dopa
- Side effects include memory loss, confusion, hallucinations, sedation.
- Therapeutic response to anticholinergic therapy wanes over time

22
Q

Botulinum toxin

A

the treatment of choice for focal dystonia such as blepharospasm, oromandibular and cervical dystonia.
- Inhibits acetylcholine exocytosis at the
neromuscular junction (chemical
denervation)
- Injected directly into the dystonic muscles.
- Botulinum toxin resistance may arise due to
antibody development

23
Q

How long does Botulinum toxin work

A

Clinical effects are seen within one week and last for 3-4 months.

24
Q

Treatments of choice

A
  • in kids: l-dopa (1st), anti-cholinergics (2)
  • In adults: Anticholinergics (1st)
  • for focal dystonia (ex. blepharospasm, oromandibular and cervical dystonia) –Botulinum toxin preferred
25
Q

How Botulinum toxin work

A

Toxin is recognized and enodcytosed –> light chain of toxin cleaves specific SNARES (incl. SNAP-25, VAMP, Syntaxin) –> prevents synaptic fusion of vesicles to membrane

26
Q

Tic

A

jerklike, coordinated stereotyped movements

27
Q

Suppression of tics

A

Most tics can be suppressed for short periods, but this causes anxiety

28
Q

Tourette’s syndrome (TS) definition

A

is a complex neurobehavioral disorder with

familial transmission–primarily motor, focal, phonic tics + OCD/ADHD

29
Q

Tourette’s syndrome (TS) charcaterized by

A
  • motor, vocal or phonic tics
  • OCD (“cognitive tics”), including self-injurious behaviour
  • attention deficit-hyperactivity disorder (ADHD)
  • coprolalia (shouting obscenities) in less than 50% of patients
  • poor impulse control
30
Q

TS pathophysiology

A
  • Involving dysfunction in several brain areas (frontal cortex, limbic system, thalamus, striatum etc)
  • Reduced caudate volume in some patients.
  • Reduced metabolic activity in striatum and thalamus consistent with a reduction in
    the indirect pathway
31
Q

TS as a developmental disorder

A

It may represent a developmental disorder resulting in dopaminergic hyper-innervation of the ventral striatum and associated limbic
system.
Also, number and distribution of interneurons might be affected

32
Q

TS affects __% of the population

A

1% but likely higher

People suppress it etc.

33
Q

TS shares genetic susceptibility with ____

A

ASD and SCZ

34
Q

Treatment of motor symptoms in TS

A
  • Antipsychotic drugs
  • Botulinum toxin focal injections
  • SSRIs
35
Q

Antipsychotic drugs in TS

A

D2 antagonists, e.g. haloperidol

are the most effective pharmacotherapy for TS

36
Q

SSRIs in TS

A

ex. clomipramine, fluoxetine, sertraline

are effective in some individuals to treat obsessive-compulsive symptoms

37
Q

Botulinum toxin in TS

A

Focal injections, often into face

used to prevent tics by preventing muscle movement